Triple-Hormone Synergy for Advanced Weight Management Research
🔬 Product Overview
Retatrutide is an advanced triple hormone receptor agonist that targets GLP-1, GIP, and glucagon receptors simultaneously. This comprehensive mechanism of action offers exceptional potential for research focused on weight loss and metabolic health. The 20mg vial provides a cost-effective solution for long-term research protocols.
🚀 Key Benefits
• Triple Hormone Activation: Simultaneously activates GLP-1, GIP, and glucagon receptors to promote synergistic effects on weight reduction and metabolic regulation.
• Remarkable Weight Loss Results: Clinical studies have shown up to 24.2% body weight reduction over 48 weeks with 12mg dosing—outperforming widely used treatments such as Ozempic and Mounjaro.
• Metabolic Health Improvement: Proven to reduce liver fat and improve key cardiometabolic markers, offering broader health benefits.
• Cost Efficiency: The 20mg vial offers a lower cost per milligram compared to the 10mg version, providing better value for extended research use.
🧪 Composition
• Active Ingredient: Retatrutide
• Concentration: 20mg per vial
• Form: Lyophilized peptide powder
📦 Usage & Storage
• Intended Use: For research purposes only
• Storage: Store lyophilized powder in a cool, dry place. After reconstitution, refrigerate at 2–8°C and use within the designated study timeframe.
🛒 Order Now:
Secure your 20mg Retatrutide vial today for just £350.
